Evidence map›Paper›PMID 41204411›Full record

ArticleJournal of applied clinical medical physics2025

Performance evaluation of a second-generation O-ring-shaped image-guided radiotherapy system with a gimbal-mounted linear accelerator and real-time tracking capabilities.

Kohei Kawata, Yukako Kishigami, Hideaki Hirashima, Yohei Sawada, Maika Urago, Takahiro Fujimoto, Tetsuo Fukuda, Takashi Mizowaki, Mitsuhiro Nakamura

Abstract readEvaluation Study
In one paragraph

Article in Journal of applied clinical medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kohei KawataDepartment of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0000-0001-7825-2986
Yukako KishigamiDepartment of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hideaki HirashimaDepartment of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0000-0003-1548-1970
Yohei SawadaDivision of Clinical Radiology Service, Kyoto University Hospital, Kyoto, Japan.
Maika UragoDivision of Clinical Radiology Service, Kyoto University Hospital, Kyoto, Japan.
Takahiro FujimotoDivision of Clinical Radiology Service, Kyoto University Hospital, Kyoto, Japan.
Tetsuo FukudaX-ray Therapy Division, Therapy System Business, Healthcare Business Group, Hitachi High-Tech Corporation, Tokyo, Japan.
Takashi MizowakiDepartment of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0000-0002-8135-8746
Mitsuhiro NakamuraDepartment of Advanced Medical Physics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0000-0002-6406-2097

Funding

Japan Agency for Medical Research and Development 24ck0106924h0001
6 · The paper itself

Abstract

purposeOXRAY, a state-of-the-art radiation therapy system commercialized by Hitachi High-Tech Ltd. in 2023, integrates unique beam delivery and image-guided radiation therapy (IGRT) technologies as the successor to Vero4DRT. This study evaluated the performance of this second-generation O-ring-shaped linear accelerator.

methodsThe percentage depth dose (PDD) and off-center ratio (OCR) were calculated using the RayStation 2023B treatment planning system with multileaf collimator-shaped square fields. PDDs were evaluated up to a depth of 250 mm and OCRs at depths of 15, 100, and 200 mm, compared with measurements. Patient-specific quality assurance (PSQA) was conducted for 28 volumetric-modulated arc therapy plans and evaluated using gamma pass rates (GPRs) based on a 3%/2 mm criterion. The biaxial rotational dynamic radiation therapy (BROAD-RT) performance was validated with 25 trajectories. A tracking experiment under rotational irradiation was performed to assess the tracking accuracy. Additionally, image-guidance systems (kV X-ray and kV cone-beam computed tomography) were evaluated using anthropomorphic phantoms. The localization accuracy (LA) was determined by comparing the known offsets with the noted differences between the initial and corrected positions.

resultsDifferences between the calculated and measured data were within the tolerance limits defined in European Society for Radiotherapy and Oncology Booklet 7 and American Association of Physicists in Medicine (AAPM) Medical Physics Practice Guideline 5.b. The median PSQA GPRs exceeded 95%, satisfying AAPM Task Group-218 criteria. BROAD-RT demonstrated submillimeter accuracy (within 0.4 mm), even for complex trajectories. The tracking accuracy remained within 1 mm even during rotational delivery. LA was within 0.5 mm for translational shifts and 0.5° for rotational adjustments.

conclusionOXRAY demonstrated clinically acceptable beam quality and high-precision dose delivery outcomes. The tracking accuracy was maintained under rotational irradiation. Automatic image registration enabled accurate, reproducible patient positioning, supporting reliable IGRT implementation. These findings offer practical guidance and technical benchmarks for institutions adopting OXRAY.

Indexed as

Image Processing, Computer-AssistedNeoplasmsParticle AcceleratorsPhantoms, ImagingQuality Assurance, Health CareRadiotherapy, Image-GuidedRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedHumansRadiotherapy DosagecommissioningIGRT verificationOXRAYTPS verificationtracking performance

Identifiers

PMID41204411
PMCPMC12594607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.